CLU and prostate neoplasm: The mechanism by which sCLU activation inthese cancer cells confers chemoresistance is unclearBecause CLU was firstdiscovered as a survival protein in prostate tumor cells, a push was made toinvestigate whether androgen ablation, irradiation, and paclitaxel treatment, whichare common strategies for treatment of this cancer, upregulated CLU.